Back to search
FDAFDA · Food and drugs·Recall number Z-1307-2014

RayStation Radiation Therapy Treatment Planning System, models 2.5, 3.0, 3.5 and 4.0; a software system designed for treatment planning and analysis of radiation therapy.

Published April 9, 2014 · Recall initiated: February 6, 2014

Summary

FDA records medical device Class II recall Z-1307-2014, published April 9, 2014 and initiated February 6, 2014. Recalling firm: RAYSEARCH LABORATORIES AB; Status: Terminated; Reported quantity: 151 units Total (88 units domestically & 63 units internationally); Lot: MODEL #(s): 2.5, 3.0, 3.5 and 4.0; VERSIONS: 2.5.1.89, 3.0.0.251, 3.5.0.16, 3.5.1.6, 4.0.0.14, 4.0.1.4, 4.0.2.9. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Potential for dose errors due to software program errors.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
RAYSEARCH LABORATORIES AB
Distributor
Worldwide Distribution - US including the states of NY, OH, MD, CT, CO, TN, IL, AZ, MS, NJ, PA, DE, FL, CA and WA., and the countries of New Zealand, Australia, Republic of Korea, China, Italy, Germany, Norway, Belgium, Switzerland, United Kingdom and Spain.
Lot
MODEL #(s): 2.5, 3.0, 3.5 and 4.0; VERSIONS: 2.5.1.89, 3.0.0.251, 3.5.0.16, 3.5.1.6, 4.0.0.14, 4.0.1.4, 4.0.2.9
Risk classification
Class II
Area (FDA)
device
Country
Sweden

Related recalls

Questions about this recall

Was RayStation Radiation Therapy Treatment Planning System, models 2.5, 3.0, 3.5 and 4.0; a software system designed for treatment planning and analysis of radiation therapy. recalled?

Yes. FDA published recall Z-1307-2014 on April 9, 2014. Reported hazard: Potential for dose errors due to software program errors.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail